To view this email as a web page, click here.

Does Age at Diagnosis Impact Clinical and Molecular Features of Colorectal Cancer?

Research published in Cancer evaluated whether colorectal cancers diagnosed in early adulthood differ from those diagnosed at older ages.

Adding Checkpoint Inhibition in Trastuzumab-Resistant HER2+ Breast Cancer

An early-phase trial tested the combination of pembrolizumab with trastuzumab in patients with PD-L1–positive, trastuzumab-resistant, advanced HER2+ breast cancer.

IN CASE YOU MISSED IT

'Real-World' Follicular Lymphoma Study Examines the Negative Effect of Early Progression

Researchers examined the effect of early progression in a real-world setting of follicular lymphoma patients.

Read more

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.